Literature DB >> 1556173

Caldesmon content of mammalian smooth muscles.

J R Haeberle1, D R Hathaway, C L Smith.   

Abstract

In the present study we have used a quantitative immunoblotting method to measure the caldesmon content of a variety of smooth muscles with distinctly different contractile phenotypes. Two tonic vascular smooth muscles and several phasic smooth muscles were examined. The caldesmon, actin and myosin contents of each muscle type were measured. Smooth muscle from large arteries (i.e. bovine aorta and porcine carotid artery) had the lowest caldesmon content and phasic muscles (e.g. rat uterus and guinea pig taenia coli) had the highest. The molar ratio of monomeric caldesmon to monomeric actin was 1:205 for the aorta and carotid artery versus 1:22-28 for the taenia coli and uterus. The molar ratio of caldesmon to monomeric myosin heavy chain was 1:9 for the aorta and carotid versus 1:2 for the uterus and taenia coli. The caldesmon contents of canine trachealis and rabbit ileum were intermediate between these extremes. Evidence was found for the presence of both tissue- and species-specific caldesmon isoforms. The relatively high caldesmon content in rat uterus and guinea pig taenia coli suggests the possibility that the contractile phenotype associated with phasic smooth muscles may be dependent on the presence of caldesmon.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1556173     DOI: 10.1007/bf01738431

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  26 in total

1.  The functional properties of full length and mutant chicken gizzard smooth muscle caldesmon expressed in Escherichia coli.

Authors:  C S Redwood; S B Marston; J Bryan; R A Cross; J Kendrick-Jones
Journal:  FEBS Lett       Date:  1990-09-17       Impact factor: 4.124

2.  Complexes between 15 kDa caldesmon fragment and actin investigated by immuno-electron microscopy.

Authors:  M C Harricane; C Cavadore; E Audemard; D Mornet
Journal:  FEBS Lett       Date:  1990-08-20       Impact factor: 4.124

3.  Phosphorylation of caldesmon prevents its interaction with smooth muscle myosin.

Authors:  C Sutherland; M P Walsh
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

4.  Functional domain of caldesmon.

Authors:  A Szpacenko; R Dabrowska
Journal:  FEBS Lett       Date:  1986-07-07       Impact factor: 4.124

5.  Phosphorylation of caldesmon in arterial smooth muscle.

Authors:  L P Adam; J R Haeberle; D R Hathaway
Journal:  J Biol Chem       Date:  1989-05-05       Impact factor: 5.157

6.  Caldesmon. Molecular weight and subunit composition by analytical ultracentrifugation.

Authors:  P Graceffa; C L Wang; W F Stafford
Journal:  J Biol Chem       Date:  1988-10-05       Impact factor: 5.157

7.  Cloning and expression of a smooth muscle caldesmon.

Authors:  J Bryan; M Imai; R Lee; P Moore; R G Cook; W G Lin
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

8.  Binding of caldesmon to smooth muscle myosin.

Authors:  M Ikebe; S Reardon
Journal:  J Biol Chem       Date:  1988-03-05       Impact factor: 5.157

9.  A radioimmunoblotting method for measuring myosin light chain phosphorylation levels in smooth muscle.

Authors:  D R Hathaway; J R Haeberle
Journal:  Am J Physiol       Date:  1985-09

10.  The binding of caldesmon to actin and its effect on the ATPase activity of soluble myosin subfragments in the presence and absence of tropomyosin.

Authors:  L Velaz; M E Hemric; C E Benson; J M Chalovich
Journal:  J Biol Chem       Date:  1989-06-05       Impact factor: 5.157

View more
  18 in total

1.  Targeted expression of SV40 large T-antigen to visceral smooth muscle induces proliferation of contractile smooth muscle cells and results in megacolon.

Authors:  B P Herring; A M Hoggatt; A F Smith; P J Gallagher
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

2.  Novel immunological technique.

Authors:  W Lehman; D Denault; S Marston
Journal:  J Muscle Res Cell Motil       Date:  1992-10       Impact factor: 2.698

Review 3.  Calponin (CaP) as a latch-bridge protein--a new concept in regulation of contractility in smooth muscles.

Authors:  Pawel T Szymanski
Journal:  J Muscle Res Cell Motil       Date:  2004       Impact factor: 2.698

4.  Immunocytochemical localization of caldesmon and calponin in chicken gizzard smooth muscle.

Authors:  K Mabuchi; Y Li; T Tao; C L Wang
Journal:  J Muscle Res Cell Motil       Date:  1996-04       Impact factor: 2.698

5.  The effects of caldesmon extraction on mechanical properties of skinned smooth muscle fibre preparations.

Authors:  U Malmqvist; A Arner; R Makuch; R Dabrowska
Journal:  Pflugers Arch       Date:  1996-06       Impact factor: 3.657

6.  Phosphorylation of caldesmon by mitogen-activated protein kinase with no effect on Ca2+ sensitivity in rabbit smooth muscle.

Authors:  G F Nixon; K Iizuka; C M Haystead; T A Haystead; A P Somlyo; A V Somlyo
Journal:  J Physiol       Date:  1995-09-01       Impact factor: 5.182

7.  Ca2+ regulation of the contractile apparatus in canine gastric smooth muscle.

Authors:  H Ozaki; W T Gerthoffer; M Hori; H Karaki; K M Sanders; N G Publicover
Journal:  J Physiol       Date:  1993-01       Impact factor: 5.182

8.  Caldesmon and a 20-kDa actin-binding fragment of caldesmon inhibit tension development in skinned gizzard muscle fiber bundles.

Authors:  G Pfitzer; C Zeugner; M Troschka; J M Chalovich
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

9.  Flexation of caldesmon: effect of conformation on the properties of caldesmon.

Authors:  R H Crosbie; J M Chalovich; E Reisler
Journal:  J Muscle Res Cell Motil       Date:  1995-10       Impact factor: 2.698

10.  A comparison of the effects of calponin on smooth and skeletal muscle actomyosin systems in the presence and absence of caldesmon.

Authors:  S J Winder; C Sutherland; M P Walsh
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.